Literature DB >> 7511493

Comparative in vitro study of contraceptive agents with anti-HIV activity: gramicidin, nonoxynol-9, and gossypol.

A S Bourinbaiar1, S Lee-Huang.   

Abstract

Gramicidin, a polypeptide antibiotic derived from Bacillus brevis, was compared in vitro with the established contraceptive virucidal agents nonoxynol-9 and gossypol for activity against human immunodeficiency virus (HIV) infection. The effective antiviral 10 ng/ml concentration of gramicidin required for complete HIV inactivation was a thousand-fold lower than the dose observed for nonoxynol-9 or gossypol. Gramicidin, routinely used as a contraceptive agent in the former Soviet Union, should be considered for in vivo trials as a spermicide with potent antiviral activity.

Entities:  

Keywords:  Americas; Antibiotics; Clinical Research; Comparative Studies; Contraception; Contraceptive Agents; Contraceptive Agents, Male; Developed Countries; Diseases; Drugs; Family Planning; Gossypol; Hiv Infections--prevention and control; In Vitro; Nonoxynol-9; North America; Northern America; Research Report; Spermicidal Contraceptive Agents; Studies; Treatment; United States; Viral Diseases

Mesh:

Substances:

Year:  1994        PMID: 7511493     DOI: 10.1016/0010-7824(94)90088-4

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  20 in total

1.  An Update on Vaginal Microbicides.

Authors:  Christine Mauck; Gustavo Doncel
Journal:  Curr Infect Dis Rep       Date:  2001-12       Impact factor: 3.725

2.  Thermoreversible gel formulations containing sodium lauryl sulfate or n-Lauroylsarcosine as potential topical microbicides against sexually transmitted diseases.

Authors:  S Roy; P Gourde; J Piret; A Désormeaux; J Lamontagne; C Haineault; R F Omar; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Anti HIV-1 virucidal activity of polyamide nucleic acid-membrane transducing peptide conjugates targeted to primer binding site of HIV-1 genome.

Authors:  Snehlata Tripathi; Binay Chaubey; Beverly E Barton; Virendra N Pandey
Journal:  Virology       Date:  2007-02-21       Impact factor: 3.616

4.  Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraception.

Authors:  Regine Sitruk-Ware; Vivian Brache; Robin Maguire; Horacio Croxatto; Narender Kumar; Sushma Kumar; Juan Carlos Montero; Ana Maria Salvatierra; David Phillips; Anibal Faundes
Journal:  Contraception       Date:  2007-04-18       Impact factor: 3.375

5.  Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides.

Authors:  P Greenhead; P Hayes; P S Watts; K G Laing; G E Griffin; R J Shattock
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

6.  Virucidal agents in the eve of manorapid synergy.

Authors:  Angel S Galabov
Journal:  GMS Krankenhhyg Interdiszip       Date:  2007-09-13

7.  In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses.

Authors:  J Piret; J Lamontagne; J Bestman-Smith; S Roy; P Gourde; A Désormeaux; R F Omar; J Juhász; M G Bergeron
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

Review 8.  The repertoire of human efforts to avoid sexually transmissible diseases: past and present. Part 2: Strategies used during or after sex.

Authors:  B Donovan
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

9.  The microbicidal agent C31G inhibits Chlamydia trachomatis infectivity in vitro.

Authors:  P B Wyrick; S T Knight; D G Gerbig; J E Raulston; C H Davis; T R Paul; D Malamud
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

Review 10.  Vaginal microbicides: a novel approach to preventing sexual transmission of HIV.

Authors:  Gustavo Doncel; Christine Mauck
Journal:  Curr HIV/AIDS Rep       Date:  2004-04       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.